Latest Breaking News On - Nitial pepg us7133171055 - Page 1 : comparemela.com

- CONNECT1-EDO51 will assess dystrophin levels, exon skipping data and safety data following multiple doses of PGN-EDO51 in patients with mutations amenable to skipping exon 51 - - Initial data. | May 18, 2023

United statesLaurence wattsJames mcarthurGilmartin groupPepgen incHealth canadaHead of clinical development at pepgenClinical trial applicationMichelle mellionClinical developmentDrug safety monitoring boardEnhanced delivery oligonucleotidePrivate securities litigation reform actPepgen inc stock exchangePress releaseNitial pepg us7133171055